Concepedia

Steven Tyler

ST

3

Publications

349

Citations

3

H-Index

2014

Active since

Affiliations

Momenta Pharmaceuticals (United States)(Current)

Steven Tyler is an author at Momenta Pharmaceuticals (United States) specializing in biomolecular engineering, autoimmunity, and drug discovery.

Top concepts

Publications per year

2014–2016

3

Publications

3

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

Nathaniel Washburn, Inessa Schwab, Daniel Ortiz et al. · Proceedings of the National Academy of Sciences · 2015 · 223 citations · Full text

, , +21

Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors

Daniel Ortiz, Jonathan C. Lansing, Laura I. Rutitzky et al. · Science Translational Medicine · 2016 · 65 citations

Neuregulin 1 Expression Is a Predictive Biomarker for Response to AV-203, an ERBB3 Inhibitory Antibody, in Human Tumor Models

Kristan Meetze, Sylvie Vincent, Steven Tyler et al. · Clinical Cancer Research · 2014 · 61 citations

Rows per page

1–3 of 3